Evidence map›Paper›PMID 35062288›Full record

ArticleViruses2022

A Functional Minigenome of Parvovirus B19.

Alessandro Reggiani, Andrea Avati, Francesca Valenti, Erika Fasano, Gloria Bua, Elisabetta Manaresi, Giorgio Gallinella

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alessandro ReggianiDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0002-4101-0956
Andrea AvatiDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0003-2985-6075
Francesca ValentiDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0002-7266-7352
Erika FasanoDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Gloria BuaDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Elisabetta ManaresiDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Giorgio GallinellaDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0003-1118-6341
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parvovirus B19 (B19V) is a human pathogenic virus of clinical relevance, characterized by a selective tropism for erythroid progenitor cells in bone marrow. Relevant information on viral characteristics and lifecycle can be obtained from experiments involving engineered genetic systems in appropriate in vitro cellular models. Previously, a B19V genome of defined consensus sequence was designed, synthesized and cloned in a complete and functional form, able to replicate and produce infectious viral particles in a producer/amplifier cell system. Based on such a system, we have now designed and produced a derived B19V minigenome, reduced to a replicon unit. The genome terminal regions were maintained in a form able to sustain viral replication, while the internal region was clipped to include only the left-side genetic set, containing the coding sequence for the functional NS1 protein. Following transfection in UT7/EpoS1 cells, this minigenome still proved competent for replication, transcription and production of NS1 protein. Further, the B19V minigenome was able to complement B19-derived, NS1-defective genomes, restoring their ability to express viral capsid proteins. The B19V genome was thus engineered to yield a two-component system, with complementing functions, providing a valuable tool for studying viral expression and genetics, suitable to further engineering for purposes of translational research.

Indexed as

Genome, ViralRepliconCell LineCloning, MolecularGenetic EngineeringHumansParvovirus B19, HumanTranscription, GeneticViral Nonstructural ProteinsVirus ReplicationNS1 protein, parvovirusViral Nonstructural Proteinsfunctional complementationgenetic engineeringparvovirus B19replicon unitsynthetic genome

Identifiers

PMID35062288
PMCPMC8780457
OpenAlexW4205817046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.